MAPT and Alzheimer disease: Immunohistochemistry and immunofluorescence techniques were employed to ascertain that the end products of advanced glycation in the brains of AD patients were augmented, which can facilitate the generation of oxygen radicals and aggregates at the site of Tau protein deposition [9].